<DOC>
	<DOC>NCT01113606</DOC>
	<brief_summary>The aims of the Skin Product Assessment Research study were to (1) develop an infrastructure and process for industry-sponsored, Plastic Surgery Educational Foundation (PSEF) research in facial aesthetic surgery and (2) test the research process by comparing outcomes of the Obagi Nu-Derm System (ODNS) and conventional therapy as treatment adjuncts in ablative facial resurfacing.</brief_summary>
	<brief_title>A Trial of Skin Care Protocols for Facial Resurfacing</brief_title>
	<detailed_description />
	<mesh_term>Facies</mesh_term>
	<criteria>patients with moderate to severe photo damage and rhytids, undergoing full or partial face resurfacing with chemical peel or ablative laser. Fitzpatrick IIV skin types patients unable to complete the regimen or who had used topical prescription steroids, retinoids, depigmentation products or other products containing hydroquinone and polyhydroxy acids within 8 weeks of enrollment.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Moderate to severe facial photo damage</keyword>
	<keyword>Periocular or perioral fine wrinkles</keyword>
</DOC>